Vidipha Central Pharmaceutical JSC (HOSE:VDP)
Vietnam · Delayed Price · Currency is VND 47,900
-100 (-0.21%)
At close: Feb 9, 2026
HOSE:VDP Revenue
In the year 2025, Vidipha Central Pharmaceutical JSC had annual revenue of 950.89B VND with 1.76% growth. Vidipha Central Pharmaceutical JSC had revenue of 156.84B in the quarter ending December 31, 2025, a decrease of -46.67%.
Revenue
950.89B
Revenue Growth
+1.76%
P/S Ratio
1.11
Revenue / Employee
4.88B
Employees
195
Market Cap
1.06T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 950.89B | 16.41B | 1.76% |
| Dec 31, 2024 | 934.49B | -84.83B | -8.32% |
| Dec 31, 2023 | 1.02T | 11.52B | 1.14% |
| Jan 1, 2023 | 1.01T | 800.84B | 386.97% |
| Dec 31, 2008 | 206.95B | 15.51B | 8.10% |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Traphaco JSC | 2.65T |
| Ha Tay Pharmaceutical JSC | 2.40T |
| Domesco Medical Import - Export Joint-Stock | 2.08T |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1.87T |
| Cuu Long Pharmaceutical JSC | 1.32T |
| Vimedimex Medi-Pharma JSC | 1.17T |
| OPC Pharmaceutical JSC | 1.12T |
| Ben Tre Pharmaceutical JSC | 860.40B |